Marketing and sales solutions (MASS) is an independent management consultancy, dedicated to ensuring our clients achieve high performance through strategic brand development and implementation excellence. Focused on the pharmaceutical and health-care industries, our objective is to add straight to your bottom line. MASS has two primary areas of focus: Strategic Consulting and Implementation Excellence.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
White Papers and Resources | November 23, 2016 | Inizio
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?
White Papers and Resources | November 23, 2016 | Inizio
As part of our continued growth, we are delighted to announce a new intake of 17 Research Analysts and 5 Fieldwork Project Coordinators into our annual market research graduate programme.http://www.researchpartnership.com/news/2016/09/new-graduates-2016/
White Papers and Resources | November 23, 2016 | Inizio
With the imminent expected approval and launch of a new product, our client needed to conduct global tracking research to understand knowledge, perceptions, awareness and recall around their product and the quality...
White Papers and Resources | November 23, 2016 | Inizio
The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by...
White Papers and Resources | November 23, 2016 | Inizio
The IBD syndicated market tracker is part of our large auto-immune portfolio
White Papers and Resources | November 23, 2016 | Inizio
Living with Lupus (SLE) is a quantitative study conducted online amongst patients in the US and European markets. The report will consist of 30-minute face to face interviews with a...
White Papers and Resources | November 23, 2016 | Inizio
A segmentation study comes with high visibility and high stakes across your marketing and sales organisations. Ensuring that a segmentation is actionable is a consistent issue, particularly when stakeholders with multiple...
White Papers and Resources | November 23, 2016 | Inizio
An overview of the six most-commonly researched, largest pharma markets in Latin America
White Papers and Resources | November 23, 2016 | Inizio
Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies,...
White Papers and Resources | November 23, 2016 | Inizio
Our client was developing a portfolio of innovative treatments and was in the process of recruiting a sales force to support the promotion of this portfolio. Research was required to...